Abstract
To compare the efficacy and safety of intravenous dihydralazine with ketanserin in the management of severe hypertension in the third trimester. A double blind randomised controlled trial, comparing 5 mg dihydralazine with 10 mg ketanserin after an intravenous infusion of 500 ml of a crystalloid solution. Medication was repeated every 20 min till the therapeutic goal of 90 mm Hg was reached, to a maximum of 4 dosages. Main outcome measures were treatment failures and emergency deliveries for fetal distress. The therapeutic goal was met more often in patients receiving dihydralazine (36/38 compared to 27/42; P < 0.01). The need for delivery for fetal distress did not differ (3 after dihydralazine, 1 after ketanserin, P = 0.29) No therapy related perinatal loss occurred, but one mother with an undiagnosed phaechromocytoma died 24 h after receiving dihydralazine. Ketanserin in this dosage is less effective to lower diastolic blood pressure. The place of a fluid load prior to dihydralazine needs to be further investigated, as fetal heart rate decelerations were less common than previously reported.
References
Jun 1, 1991·Hypertension·W Visser, H C Wallenburg
Nov 1, 1990·American Journal of Obstetrics and Gynecology
Aug 1, 1986·American Journal of Obstetrics and Gynecology·V A Hulme, H J Odendaal
May 1, 1986·Southern Medical Journal·J A SpinnatoG D Anderson
Jul 1, 1984·American Journal of Obstetrics and Gynecology·C P WeinerM L Socol
Sep 1, 1994·Acta Obstetricia Et Gynecologica Scandinavica·D Wide-SwenssonI Ingemarsson
May 1, 1994·British Journal of Obstetrics and Gynaecology·S Paterson-BrownM de Swiet
Sep 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·T J SchneiderH C Wallenburg
Jun 12, 1999·Anaesthesia·J A Crowhurst, F Plaat
Aug 5, 2000·The Australian & New Zealand Journal of Obstetrics & Gynaecology·M A BrownUNKNOWN Australasian Society for the Study of Hypertension in Pregnancy
Citations
Aug 29, 1998·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·J T Repke, J N Robinson
Mar 27, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·A C BolteG A Dekker
Apr 13, 2002·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Debby L van SchieHerman P van Geijn
Sep 7, 2000·Obstetrical & Gynecological Survey·D W Steyn, H J Odendaal
Apr 5, 2005·Clinical Obstetrics and Gynecology·Peter von Dadelszen, Laura A Magee
Oct 25, 2003·BMJ : British Medical Journal·Laura A MageePeter von Dadelszen
Aug 2, 2001·Best Practice & Research. Clinical Obstetrics & Gynaecology·F Paruk, J Moodley
Nov 14, 2007·Metabolism: Clinical and Experimental·Niels BoonWim H M Saris
Jul 6, 2018·British Journal of Clinical Pharmacology·Kannan Sridharan, Reginald P Sequeira
Jul 14, 2007·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Annemarie HennessyAndrew Child
Aug 1, 2013·The Cochrane Database of Systematic Reviews·Lelia DuleyLeanne Jones
Feb 8, 2014·The Cochrane Database of Systematic Reviews·Edgardo AbalosD Wilhelm Steyn